1. Home
  2. ACV vs BWAY Comparison

ACV vs BWAY Comparison

Compare ACV & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACV
  • BWAY
  • Stock Information
  • Founded
  • ACV 2015
  • BWAY 2003
  • Country
  • ACV United States
  • BWAY Israel
  • Employees
  • ACV N/A
  • BWAY N/A
  • Industry
  • ACV Finance/Investors Services
  • BWAY Medical/Dental Instruments
  • Sector
  • ACV Finance
  • BWAY Health Care
  • Exchange
  • ACV Nasdaq
  • BWAY Nasdaq
  • Market Cap
  • ACV 253.6M
  • BWAY 280.7M
  • IPO Year
  • ACV N/A
  • BWAY 2019
  • Fundamental
  • Price
  • ACV $25.34
  • BWAY $16.59
  • Analyst Decision
  • ACV
  • BWAY Strong Buy
  • Analyst Count
  • ACV 0
  • BWAY 2
  • Target Price
  • ACV N/A
  • BWAY $18.00
  • AVG Volume (30 Days)
  • ACV 38.8K
  • BWAY 61.1K
  • Earning Date
  • ACV 01-01-0001
  • BWAY 11-11-2025
  • Dividend Yield
  • ACV 9.20%
  • BWAY N/A
  • EPS Growth
  • ACV N/A
  • BWAY 679.98
  • EPS
  • ACV N/A
  • BWAY 0.11
  • Revenue
  • ACV N/A
  • BWAY $46,084,000.00
  • Revenue This Year
  • ACV N/A
  • BWAY $335.63
  • Revenue Next Year
  • ACV N/A
  • BWAY $22.10
  • P/E Ratio
  • ACV N/A
  • BWAY $58.95
  • Revenue Growth
  • ACV N/A
  • BWAY 26.50
  • 52 Week Low
  • ACV $16.82
  • BWAY $7.84
  • 52 Week High
  • ACV $23.74
  • BWAY $17.49
  • Technical
  • Relative Strength Index (RSI)
  • ACV 67.84
  • BWAY 61.04
  • Support Level
  • ACV $24.22
  • BWAY $15.36
  • Resistance Level
  • ACV $25.20
  • BWAY $16.34
  • Average True Range (ATR)
  • ACV 0.47
  • BWAY 0.72
  • MACD
  • ACV 0.00
  • BWAY 0.11
  • Stochastic Oscillator
  • ACV 91.26
  • BWAY 69.22

About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest

Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: